The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
On July 10, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…
This blog will feature weekly updates from our Socioeconomic Committee and Health Policy team to…
From the AMA Advocacy Update Newsletter, May 17, 2024 In a letter (PDF) to the Medicare Payment…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 30, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Michelle Liu, MD joined the host of the BackTable ENT Podcast, Dr. Ashley Agan, to…
Sitting here at the Basic Course I cannot help by be inspired. Such a great…
Does it seem like everything old is new again? The 70s seem to be back…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
By Haidy Marzouk, MD; Nalin Patel, MD Wondering what the evidence shows in terms of pediatric otitis media and allergies shows? What’s the best approach to children with recurrent issues, especially after placement of tympanostomy tubes? What should we counsel…
July 2021 marks an almost 18 month journey through COVID. We have witnessed and personally experienced the loss of human lives due to the coronavirus. We have experienced significant shifts in workload and scope of practice and have felt the…
AAOA's "Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin. The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases. Biologic…
Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to the office and outpatient evaluation and management (E/M) services (CPT codes 99202-99215) for both new and established patients. Specially, CMS increased the valuations for the…
Joint Statement by the American Academy of Otolaryngology–Head and Neck Surgery (AAO–HNS) and the American Academy of Otolaryngic Allergy (AAOA) Allergic reactions are uncommon and anaphylaxis following vaccines is rare, occurring at a rate of approximately one per million doses…
With the advent of the vaccine comes new questions and concerns. To help you address those with your staff and patients, AAOA has outlined some FAQs and resource links. We will continue to update this FAQ as more information becomes available…
To help members who are having trouble acquiring PPE, AAOA is collaborating with Project N95 to purchase N95 respirators (certified by CDC and NIOSH), nitrile powder free gloves, Level 1 and Level 2 AAMI isolation gowns, ASTM Level 1 and…
Alpen Patel, MD, FAAOA on changes caused by the COVID-19 pandemic and AAOA member resources and virtual events. https://youtu.be/_Cn-vmrR3OQ If you have any questions or feedback, please contact AAOA at (202) 955-5010 or email to [email protected]. COVID-19 Resources Resuming SCIT…
Release Date: August 14, 2020; Expiration Date: August 13, 2021 Nasal polyps impact an estimated 13 million Americans. In particular, nasal polyps affect 45% of people with adult-onset asthma and approximately 30% of people with chronic rhinosinusitis, in the latter,…
From the AAOA President, Aplen Patel, MD, FAAOAI hope this message finds you healthy and well. The COVID-19 pandemic has upended our lives, both personally and professionally. The impact of this virus outbreak has been far-reaching. How we live and…
